<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR1">
 <label>1.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Agata</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Ura</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Yoshida</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Shinshi</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Sasaki</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Hyakkoku</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Taniguchi</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Shimamoto</surname>
    <given-names>K</given-names>
   </name>
  </person-group>
  <article-title>Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme</article-title>
  <source>Hypertens Res</source>
  <year>2006</year>
  <volume>29</volume>
  <fpage>865</fpage>
  <lpage>874</lpage>
  <pub-id pub-id-type="doi">10.1291/hypres.29.865</pub-id>
  <?supplied-pmid 17345786?>
  <pub-id pub-id-type="pmid">17345786</pub-id>
 </element-citation>
</ref>
